Leukemia, Promyelocytic, Acute
"Leukemia, Promyelocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
Concept/Terms
Leukemia, Promyelocytic, Acute- Leukemia, Promyelocytic, Acute
- Promyelocytic Leukemia, Acute
- Acute Promyelocytic Leukemia
- Acute Promyelocytic Leukemias
- Leukemia, Acute Promyelocytic
- Leukemias, Acute Promyelocytic
- Promyelocytic Leukemias, Acute
- Myeloid Leukemia, Acute, M3
- Progranulocytic Leukemia
- Leukemia, Myeloid, Acute, M3
- Leukemia, Progranulocytic
- Leukemias, Progranulocytic
- Progranulocytic Leukemias
Below are MeSH descriptors whose meaning is more general than "Leukemia, Promyelocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Promyelocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Promyelocytic, Acute" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Promyelocytic, Acute" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 5 | 6 | 11 |
| 1994 | 3 | 6 | 9 |
| 1995 | 2 | 2 | 4 |
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 3 | 1 | 4 |
| 2003 | 4 | 3 | 7 |
| 2004 | 3 | 0 | 3 |
| 2005 | 8 | 1 | 9 |
| 2006 | 5 | 1 | 6 |
| 2007 | 2 | 2 | 4 |
| 2008 | 7 | 0 | 7 |
| 2009 | 4 | 0 | 4 |
| 2010 | 8 | 0 | 8 |
| 2011 | 5 | 0 | 5 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 0 | 6 |
| 2014 | 5 | 0 | 5 |
| 2015 | 3 | 2 | 5 |
| 2016 | 2 | 0 | 2 |
| 2017 | 6 | 0 | 6 |
| 2018 | 2 | 1 | 3 |
| 2019 | 8 | 1 | 9 |
| 2020 | 4 | 2 | 6 |
| 2021 | 1 | 0 | 1 |
| 2022 | 4 | 0 | 4 |
Below are the most recent publications written about "Leukemia, Promyelocytic, Acute" by people in Profiles.
-
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. Br J Haematol. 2023 01; 200(2):170-174.
-
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia. Blood Adv. 2022 06 14; 6(11):3433-3439.
-
AML with t(8;16) mimicking acute promyelocytic leukaemia. Int J Lab Hematol. 2022 12; 44(6):997-998.
-
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm. Blood Adv. 2022 02 22; 6(4):1137-1142.
-
Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia. Nat Methods. 2021 03; 18(3):293-302.
-
RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events. Leuk Lymphoma. 2020 12; 61(13):3066-3077.
-
Handoffs and Fumbles. Circ Cardiovasc Qual Outcomes. 2020 08; 13(8):e006365.
-
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Sci Rep. 2020 06 25; 10(1):10315.
-
Nuclear body phase separation drives telomere clustering in ALT cancer cells. Mol Biol Cell. 2020 08 15; 31(18):2048-2056.
-
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535). Blood Adv. 2020 04 28; 4(8):1683-1689.